Vitamin D prevents hypoxia/reoxygenation-induced blood-brain barrier disruption via vitamin D receptor-mediated NF-kB signaling pathways

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Won, Soonmi ^a   Sayeed, Iqbal ^a   Peterson, Bethany L ^a   Wali, Bushra ^a   Kahn, Jared S ^a   Stein, Donald G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84946179288     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122821     Document Type: Article

References (54)

1. Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S. Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol. 2004;56:468-477. PMID: 15389899
2. Chen B, Friedman B, Cheng Q, Tsai P, Schim E, Kleinfeld D, et al. Severe blood-brain barrier disruption and surrounding tissue injury. Stroke. 2009;40:e666-674. doi: 10.1161/STROKEAHA.109.551341 PMID: 19893002
3. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005;57:173-185. PMID: 15914466
4. Sandoval KE, Witt KA. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis. 2008;32:200-219. doi: 10.1016/j.nbd.2008.08.005 PMID: 18790057
5. Won S, Lee JH, Wali B, Stein DG, Sayeed I. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway. J Cereb Blood Flow Metab. 2014;34:72-80. doi: 10.1038/jcbfm.2013.163 PMID: 24045404
6. Al Ahmad A, Gassmann M, Ogunshola OO. Involvement of oxidative stress in hypoxia-induced bloodbrain barrier breakdown. Microvasc Res. 2012;84:222-225. doi: 10.1016/j.mvr.2012.05.008 PMID: 22668821
7. Pun PB, Lu J, Moochhala S. Involvement of ROS in BBB dysfunction. Free Radic Res. 2009;43:348-364. doi: 10.1080/10715760902751902 PMID: 19241241
8. Wang LF, Li X, Gao YB, Wang SM, Zhao L, Dong J, et al. Activation of VEGF/Flk-1-ERK Pathway Induced Blood-Brain Barrier Injury After Microwave Exposure. Mol Neurobiol. 2014.
9. Eelen G, Verlinden L, Van Camp M, Van Hummelen P, Marchal K, De Moor B, et al. The effects of 1alpha, 25-dihydroxyvitamin D3 on the expression of DNA replication genes. J Bone Miner Res. 2004;19:133-146. PMID: 14753745
10. Peterlik M, Cross HS. Vitamin D and calcium insufficiency-related chronic diseases: molecular and cellular pathophysiology. Eur J Clin Nutr. 2009;63:1377-1386. doi: 10.1038/ejcn. 2009.105 PMID: 19724293
11. Balden R, Selvamani A, Sohrabji F. Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats. Endocrinology. 2012;153:2420-2435. doi: 10.1210/en. 2011-1783 PMID: 22408173
12. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002;13:100-105. PMID: 11893522
13. Gombart AF. The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol. 2009;4:1151-1165. doi: 10.2217/fmb.09.87 PMID: 19895218
14. Chen S, Law CS, Grigsby CL, Olsen K, Hong TT, Zhang Y, et al. Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation. 2011;124:1838-1847. doi: 10. 1161/CIRCULATIONAHA.111.032680 PMID: 21947295
15. Yuan W, Li G, Gil ES, Lowe TL, Fu BM. Effect of surface charge of immortalized mouse cerebral endothelial cell monolayer on transport of charged solutes. Ann Biomed Eng. 2010;38:1463-1472. doi: 10. 1007/s10439-010-9920-x PMID: 20087768
16. Brown RC, Morris AP, O'Neil RG. Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res. 2007;1130:17-30. PMID: 17169347
17. Nicolazzo JA, Charman SA, Charman WN. Methods to assess drug permeability across the bloodbrain barrier. J Pharm Pharmacol. 2006;58:281-293. PMID: 16536894
18. Naik P, Cucullo L. In vitro blood-brain barrier models: current and perspective technologies. J Pharm Sci. 2012;101:1337-1354. doi: 10.1002/jps.23022 PMID: 22213383
19. Hwang IK, Yoo KY, Kim Do H, Lee BH, Kwon YG, Won MH. Time course of changes in pyridoxal 5'-phosphate (vitamin B6 active form) and its neuroprotection in experimental ischemic damage. Exp Neurol. 2007;206:114-125. PMID: 17531224
20. Kandzari DE, Dery JP, Armstrong PW, Douglas DA, Zettler ME, Hidinger GK, et al. MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injury. Expert Opin Investig Drugs. 2005;14:1435-1442. PMID: 16255681
21. Watson PM, Paterson JC, Thom G, Ginman U, Lundquist S, Webster CI. Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier. BMC Neurosci. 2013;14:59. doi: 10.1186/1471-2202-14-59 PMID: 23773766
22. Patel SR, Ke HQ, Vanholder R, Koenig RJ, Hsu CH. Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins. J Clin Invest. 1995;96:50-59. PMID: 7615822
23. Takata F, Dohgu S, Yamauchi A, Matsumoto J, Machida T, Fujishita K, et al. In vitro blood-brain barrier models using brain capillary endothelial cells isolated from neonatal and adult rats retain age-related barrier properties. PLoS One. 2013;8:e55166. doi: 10.1371/journal.pone.0055166 PMID: 23383092
24. Deli MA, Abraham CS, Kataoka Y, Niwa M. Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell Mol Neurobiol. 2005;25:59-127. PMID: 15962509
25. Jiao H, Wang Z, Liu Y, Wang P, Xue Y. Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult. J Mol Neurosci. 2011;44:130-139. doi: 10.1007/s12031-011-9496-4 PMID: 21318404
26. Mark KS, Davis TP. Cerebral microvascular changes in permeability and tight junctions induced by hypoxiareoxygenation. Am J Physiol Heart Circ Physiol. 2002;282:H1485-1494. PMID: 11893586
27. Li G, Simon MJ, Cancel LM, Shi ZD, Ji X, Tarbell JM, et al. Permeability of endothelial and astrocyte cocultures: in vitro blood-brain barrier models for drug delivery studies. Ann Biomed Eng. 2010;38:2499-2511. doi: 10.1007/s10439-010-0023-5 PMID: 20361260
28. Fischer S, Wobben M, Marti HH, Renz D, Schaper W. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res. 2002;63:70-80. PMID: 11749074
29. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57:178-201. doi: 10.1016/j.neuron. 2008.01.003 PMID: 18215617
30. Kyaw T, Winship A, Tay C, Kanellakis P, Hosseini H, Cao A, et al. Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice. Circulation. 2013;127:1028-1039. doi: 10.1161/CIRCULATIONAHA.112.001347 PMID: 23395974
31. Kuckleburg CJ, Tiwari R, Czuprynski CJ. Endothelial cell apoptosis induced by bacteria-activated platelets requires caspase-8 and -9 and generation of reactive oxygen species. Thromb Haemost. 2008;99:363-372. doi: 10.1160/TH07-07-0474 PMID: 18278187
32. Kuhlmann CR, Zehendner CM, Gerigk M, Closhen D, Bender B, Friedl P, et al. MK801 blocks hypoxic blood-brain-barrier disruption and leukocyte adhesion. Neurosci Lett. 2009;449:168-172. doi: 10. 1016/j.neulet.2008.10.096 PMID: 18996441
33. Engelhardt S, Patkar S, Ogunshola OO. Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia. Br J Pharmacol. 2014;171:1210-1230. doi: 10.1111/bph.12489 PMID: 24641185
34. Fatma N, Kubo E, Sen M, Agarwal N, Thoreson WB, Camras CB, et al. Peroxiredoxin 6 delivery attenuates TNF-alpha- and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca2+ homeostasis. Brain Res. 2008;1233:63-78. doi: 10.1016/j.brainres.2008.07.076 PMID: 18694738
35. Fatma N, Kubo E, Takamura Y, Ishihara K, Garcia C, Beebe DC, et al. Loss of NF-kappaB control and repression of Prdx6 gene transcription by reactive oxygen species-driven SMAD3-mediated transforming growth factor beta signaling. J Biol Chem. 2009;284:22758-22772. doi: 10.1074/jbc. M109. 016071 PMID: 19553668
36. Qin L, Crews FT. NADPH oxidase and reactive oxygen species contribute to alcohol-induced microglial activation and neurodegeneration. J Neuroinflammation. 2012;9:5. doi: 10.1186/1742-2094-9-5 PMID: 22240163
37. Itoh Y, Takaoka R, Ohira M, Abe T, Tanahashi N, Suzuki N. Reactive oxygen species generated by mitochondrial injury in human brain microvessel endothelial cells. Clin Hemorheol Microcirc. 2006;34:163-168. PMID: 16543632
38. Koong AC, Chen EY, Giaccia AJ. Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res. 1994;54:1425-1430. PMID: 8137243
39. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 1996;10:709-720. PMID: 8635688
40. May MJ, Ghosh S. Signal transduction through NF-kappa B. Immunol Today. 1998;19:80-88. PMID: 9509763
41. Tse AK, Zhu GY, Wan CK, Shen XL, Yu ZL, Fong WF. 1alpha, 25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells. Mol Immunol. 2010;47:1728-1738. doi: 10.1016/j.molimm.2010.03.004 PMID: 20371119
42. Janjetovic Z, Zmijewski MA, Tuckey RC, De Leon DA, Nguyen MN, Pfeffer LM, et al. 20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes. PLoS One. 2009;4:e5988. doi: 10.1371/journal.pone. 0005988 PMID: 19543524
43. Liu J, Jin X, Liu KJ, Liu W. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J Neurosci. 2012;32:3044-3057. doi: 10.1523/JNEUROSCI.6409-11.2012 PMID: 22378877
44. Yang MZ, Mun CH, Choi YJ, Baik JH, Park KA, Lee WT, et al. Agmatine inhibits matrix metalloproteinase-9 via endothelial nitric oxide synthase in cerebral endothelial cells. Neurol Res. 2007;29:749-754. PMID: 17588309
45. McColl BW, Rothwell NJ, Allan SM. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J Neurosci. 2008;28:9451-9462. doi: 10.1523/JNEUROSCI.2674-08.2008 PMID: 18799677
46. Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke. 1998;29:2189-2195. PMID: 9756602
47. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J Leukoc Biol. 1994;55:410-422. PMID: 7509844
48. Navaratna D, Guo S, Arai K, Lo EH. Mechanisms and targets for angiogenic therapy after stroke. Cell Adh Migr. 2009;3:216-223. PMID: 19363301
49. Beer TM, Eilers KM, Garzotto M, Egorin MJ, Lowe BA, Henner WD. Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer. J Clin Oncol. 2003;21:123-128. PMID: 12506180
50. Nakagawa K, Sasaki Y, Kato S, Kubodera N, Okano T. 22-Oxa-1alpha, 25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. Carcinogenesis. 2005;26:1044-1054. PMID: 15718253
51. Grundmann M, Haidar M, Placzko S, Niendorf R, Darashchonak N, Hubel CA, et al. Vitamin D improves the angiogenic properties of endothelial progenitor cells. Am J Physiol Cell Physiol. 2012;303:C954-962. doi: 10.1152/ajpcell.00030.2012 PMID: 22932684
52. Zhang ZG, Zhang L, Tsang W, Soltanian-Zadeh H, Morris D, Zhang R, et al. Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab. 2002;22:379-392. PMID: 11919509
53. Van Bruggen N, Thibodeaux H, Palmer JT, Lee WP, Fu L, Cairns B, et al. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest. 1999;104:1613-1620. PMID: 10587525
54. Kastrup A, Groschel K, Ringer TM, Redecker C, Cordesmeyer R, Witte OW, et al. Early disruption of the blood-brain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke. Stroke. 2008;39:2385-2387. doi: 10.1161/STROKEAHA.107.505420 PMID: 18556588